| Log In | Register Now
Top Stories 1 of 3
PrintEmailOrder ReprintsJanuary 25, 2013 6:04 PM EST
Biocon(BION.NS), India's top listed biotech firm, plans to launch psoriasis drug Alzumab in the country in the July-September quarter, a top company executive said on Friday.
Reuters/Jagadeesh Nv/Files
Kiran Mazumdar-Shaw, chairman and managing director of Biocon Ltd., speaks during a news conference in Bangalore March 8, 2007.
The company expects sales of 1 billion rupees from the drug over four years, Kiran Mazumdar-Shaw, chairman, Biocon said in a conference call.
Late on Thursday, Biocon reported an 8.24 percent rise in net profit to 920 million rupees for the Oct-Dec quarter compared with a year earlier.
Australia Bids Adieu to Adam Spencer's Mornings on ABC's "702 Breakfast" Show [PHOTOS]
Top 10 Hottest Celebrities with Shocking Weight Loss (And Find Out Their Secrets!) [PHOTOS]
Mars Curiosity Rover Photos: UFO Hunter Spots Strange 'Ruins,' 'Missile' [PHOTOS, VIDEO]
Miranda Kerr Exposes Breasts to Crew, Wardrobe Malfunction 'Deliberate Accident?' [PHOTOS]PrintEmailOrder Reprints
Man with Largest Penis Sings About His Situation; MTV Goes Viral (VIDEO)
iPhone 6, iPhone 5S Will Have Flexible Screens Made of Corning Gorilla Glass on Release Date?
TOP PICKS
Ford to Close Plants, 1200 Australians to Lose Their Jobs
Ford Formalizes Closure of Australian Plants: Telltale Signs Strong in 2012
China's Local Governments To Open New Airports Across Nation, Banking On Economic PotentialWe value your privacy. Your email address will not be shared.
